Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Mar 21;82(8):1396–1402. doi: 10.1054/bjoc.1999.1083

Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol

A Atra 1, J D Imeson 2, R Hobson 2, M Gerrard 3, I M Hann 4, O B Eden 5, R L Carter 1, C R Pinkerton 1
PMCID: PMC2363364  PMID: 10780517

Abstract

From July 1990 to March 1996, 112 children with stage III or IV B-cell non-Hodgkin's lymphoma (B-NHL) with up to 70% FAB L3-type blasts (n= 42) in the bone marrow without central nervous system (CNS) disease were treated on the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol (identical to the French LMB 84). The median age was 8.3 years. There were 81 boys and 31 girls. According to the extent of the primary disease, patients were sub-staged into three groups: IIIA with unresectable abdominal tumour (n= 39); IIIB with abdominal multiorgan involvement (n= 57) and IIIX with extra-abdominal primary lymphoma often presenting as pleural effusion (n= 16). Univariate and multivariate analyses were carried out to evaluate the prognostic significance of lactate dehydrogenase (LDH) level at diagnosis, the sub-stage and the time to achieve complete remission (CR). With a median follow up of 48 months (range 12–92), the overall and event free survival (EFS) is 87% (95% confidence interval (CI) 79.2–92.1%) and 83.7% (95% CI 76.3–89.2%) respectively. Six patients (5.4%) never achieved CR, of whom one is alive following high-dose therapy. Eight patients (7.1%) relapsed after achieving CR, three are alive after second-line therapy. There were three early toxic deaths (2.7%), mainly from infection, and one late death from a second cancer. There was no significant difference in EFS according to LDH level at diagnosis, the sub-stage or the time to CR. This study confirms the overall good prognosis and low rate of toxic deaths in patients with advanced B-NHL treated with this intensive regimen. No significant difference in EFS according to the sub-stage, the time to achieve CR or LDH level at diagnosis making it difficult to identify a group that should not receive intensive therapy. © 2000 Cancer Research Campaign

Keywords: childhood, B-cell non-Hodgkin's lymphoma, advanced stage III and IV, UKCCSG 9002 protocol

Full Text

The Full Text of this article is available as a PDF (96.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Attar A., Pritchard J., Al-Saleem T., Al-Naimi M., Alash N., Attra A. Intensive chemotherapy for non-localised Burkitt's lymphoma. Arch Dis Child. 1986 Oct;61(10):1013–1019. doi: 10.1136/adc.61.10.1013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Allegretta G. J., Weisman S. J., Altman A. J. Oncologic emergencies I. Metabolic and space-occupying consequences of cancer and cancer treatment. Pediatr Clin North Am. 1985 Jun;32(3):601–611. doi: 10.1016/s0031-3955(16)34826-x. [DOI] [PubMed] [Google Scholar]
  3. Atra A., Gerrard M., Hobson R., Imeson J. D., Ashley S., Pinkerton C. R. Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin's lymphoma (B-NHL)--results of the UKCCSG 9003 protocol. Br J Cancer. 1998 Jun;77(12):2281–2285. doi: 10.1038/bjc.1998.379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bowman W. P., Shuster J. J., Cook B., Griffin T., Behm F., Pullen J., Link M., Head D., Carroll A., Berard C. Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study. J Clin Oncol. 1996 Apr;14(4):1252–1261. doi: 10.1200/JCO.1996.14.4.1252. [DOI] [PubMed] [Google Scholar]
  5. Hann I. M., Eden O. B., Barnes J., Pinkerton C. R. 'MACHO' chemotherapy for stage IV B cell lymphoma and B cell acute lymphoblastic leukaemia of childhood. United Kingdom Children's Cancer Study Group (UKCCSG). Br J Haematol. 1990 Nov;76(3):359–364. doi: 10.1111/j.1365-2141.1990.tb06368.x. [DOI] [PubMed] [Google Scholar]
  6. Miron I., Frappaz D., Brunat-Mentigny M., Combaret V., Buclon M., Bouffet E., Thiesse P., Ragg S., Bailly C., Philip T. Initial management of advanced Burkitt lymphoma in children: is there still a place for surgery? Pediatr Hematol Oncol. 1997 Nov-Dec;14(6):555–561. doi: 10.3109/08880019709030912. [DOI] [PubMed] [Google Scholar]
  7. Patte C., Philip T., Rodary C., Bernard A., Zucker J. M., Bernard J. L., Robert A., Rialland X., Benz-Lemoine E., Demeocq F. Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society. J Clin Oncol. 1986 Aug;4(8):1219–1226. doi: 10.1200/JCO.1986.4.8.1219. [DOI] [PubMed] [Google Scholar]
  8. Patte C., Philip T., Rodary C., Zucker J. M., Behrendt H., Gentet J. C., Lamagnère J. P., Otten J., Dufillot D., Pein F. High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Clin Oncol. 1991 Jan;9(1):123–132. doi: 10.1200/JCO.1991.9.1.123. [DOI] [PubMed] [Google Scholar]
  9. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Philip T., Hartmann O., Pinkerton R., Zucker J. M., Gentet J. C., Lamagnere J. P., Berhendt H., Perel Y., Otten J., Lutz P. Curability of relapsed childhood B-cell non-Hodgkin's lymphoma after intensive first line therapy: a report from the Société Française d'Oncologie Pédiatrique. Blood. 1993 Apr 15;81(8):2003–2006. [PubMed] [Google Scholar]
  11. Philip T., Lenoir G. M., Bryon P. A., Gerard-Marchant R., Souillet G., Philippe N., Freycon F., Brunat-Mentigny M. Burkitt-type lymphoma in France among non-Hodgkin malignant lymphomas in Caucasian children. Br J Cancer. 1982 May;45(5):670–678. doi: 10.1038/bjc.1982.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Philip T., Pinkerton R., Biron P., Ladjadj Y., Bouffet E., Souillet G., Philippe N., Frappaz D., Freycon F., Chauvin F. Effective multiagent chemotherapy in children with advanced B-cell lymphoma: who remains the high risk patient? Br J Haematol. 1987 Feb;65(2):159–164. doi: 10.1111/j.1365-2141.1987.tb02258.x. [DOI] [PubMed] [Google Scholar]
  13. Pinkerton C. R., Hann I., Eden O. B., Gerrard M., Berry J., Mott M. G. Outcome in stage III non-Hodgkin's lymphoma in children (UKCCSG study NHL 86)--how much treatment is needed? United Kingdom Children's Cancer Study Group. Br J Cancer. 1991 Sep;64(3):583–587. doi: 10.1038/bjc.1991.354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Reiter A., Schrappe M., Parwaresch R., Henze G., Müller-Weihrich S., Sauter S., Sykora K. W., Ludwig W. D., Gadner H., Riehm H. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group. J Clin Oncol. 1995 Feb;13(2):359–372. doi: 10.1200/JCO.1995.13.2.359. [DOI] [PubMed] [Google Scholar]
  15. Rothman K. J. Estimation of confidence limits for the cumulative probability of survival in life table analysis. J Chronic Dis. 1978;31(8):557–560. doi: 10.1016/0021-9681(78)90043-7. [DOI] [PubMed] [Google Scholar]
  16. Sweetenham J. W., Liberti G., Pearce R., Taghipour G., Santini G., Goldstone A. H. High-dose therapy and autologous bone marrow transplantation for adult patients with lymphoblastic lymphoma: results of the European Group for Bone Marrow Transplantation. J Clin Oncol. 1994 Jul;12(7):1358–1365. doi: 10.1200/JCO.1994.12.7.1358. [DOI] [PubMed] [Google Scholar]
  17. al-Attar A., Attra A., al-Bagdadi R., al-Naimi M., al-Saleem T., Pritchard J. 'Debulking' surgery is unnecessary in advanced abdominal Burkitt lymphoma in Iraq. Br J Cancer. 1989 Apr;59(4):610–612. doi: 10.1038/bjc.1989.123. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES